PRESS RELEASE

Q1 FY2027 — Press release

Q1 FY2027PDF · 16 pages217 KB
News Release The Procter & Gamble Company
One P&G Plaza
Cincinnati, OH 45202
P&G ANNOUNCES FISCAL YEAR 2027 FIRST QUARTER RESULTS
Net Sales +4.0%; Organic Sales +4.0%
Diluted EPS $1.97, +1%; Core EPS $2.00, +1%
UPDATES NET SALES GUIDANCE FOR THORNE ACQUISITION
MAINTAINS FISCAL YEAR ORGANIC SALES, EPS GROWTH AND CASH RETURN GUIDANCE
CINCINNATI, October 22, 2026 - The Procter & Gamble Company (NYSE:PG) reported first
quarter fiscal year 2027 net sales of $23.3 billion, an increase of four percent versus the prior year.
Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, also
increased four percent versus the prior year. Diluted net earnings per share were $1.97, an increase of one
percent versus prior year as the increase in net sales was partially offset by an increase in operating costs.
Core earnings per share were $2.00, an increase of one percent versus the prior year.
Operating cash flow was $5.8 billion, and net earnings were $4.8 billion for the quarter. Free cash
flow productivity was 93%. Free cash flow productivity is calculated as operating cash flow less capital
spending, as a percentage of net earnings. The Company returned $3.9 billion of cash to shareowners via
$2.6 billion of dividend payments and $1.3 billion of share repurchases.
First Quarter ($ billions, except EPS)
GAAP 2027 2026 % Change Non-GAAP* 2027 2026 % Change
Net Sales 23.3 22.4 4.0% Organic Sales n/a n/a 4.0%
Diluted EPS 1.97 1.95 1% Core EPS 2.00 1.99 1%
*Please refer to Exhibit 1 - Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures.
“Our solid sales, earnings and cash results in the first quarter reflect sharpened execution of our
integrated strategy” said Shailesh Jejurikar, Chairman of the Board, President and Chief Executive
Officer. “While we expect there will continue to be geopolitical and economic challenges, this strong start
keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and
free cash flow productivity for the fiscal year. We remain committed to our strategy to delight consumers
with superior products at a superior value by putting the consumer first in everything we do. We are
confident in the near term and excited about the future.”

-- 1 of 16 --

July - September Quarter Discussion
Net sales in the first quarter of fiscal year 2027 were $23.3 billion, a four percent increase versus
the prior year. Organic sales, which exclude the impacts of foreign exchange and acquisitions and
divestitures, also increased four percent driven by a two percent increase from volume and a one percent
increase from favorable mix. Pricing had a minor positive impact on sales for the quarter.
July - September 2026
Volume Foreign
Exchange Price Mix A&D (2) Net Sales Organic
Volume Organic
Sales	Net Sales Drivers (1)
Beauty 2.2% 1.1% 0.7% 2.5% —% 6.4% 2.2% 5.4%
Grooming (0.4)% (0.4)% 3.5% 1.5% (0.1)% 4.0% (0.4)% 4.5%
Health Care (2.9)% 0.4% 2.8% 2.8% (0.1)% 3.1% (2.9)% 2.7%
Fabric & Home Care 4.3% (0.6)% (0.3)% 0.8% —% 4.2% 4.3% 4.8%
Baby, Feminine & Family Care 2.3% (0.1)% (1.2)% 1.8% —% 2.9% 2.3% 3.0%
Total P&G 2.4% —% 0.4% 1.1% —% 4.0% 2.4% 4.0%
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2) Acquisitions and Divestitures excluding volume impact.
• Beauty segment organic sales increased five percent versus year ago. Hair Care organic sales increased
mid-single digits driven by innovation-based pricing in North America and Latin America, favorable
product mix and an increase in unit volume. Personal Care organic sales increased mid-single digits
driven by volume growth in Greater China and Europe and favorable product mix, partially offset by
trade investments. Skin Care organic sales increased mid-single digits due to favorable premium
product mix and a unit volume increase in North America.
• Grooming segment organic sales increased five percent versus year ago driven by innovation-based
pricing, primarily in North America and IMETA, and favorable product mix.
• Health Care segment organic sales increased three percent versus year ago. Oral Care organic sales
increased low single digits driven by premium product mix and innovation-based pricing, partially
offset by a unit volume decline. Personal Health Care organic sales increased low single digits due to
higher pricing, primarily in North America and Latin America, and favorable product mix, partially
offset by a unit volume decline.
• Fabric and Home Care segment organic sales increased five percent versus year ago. Fabric Care
organic sales increased mid-single digits driven by volume increases in North America and Europe and
favorable geographic mix. Home Care organic sales also increased mid-single digits driven by volume
increases in North America and Europe and favorable product mix.

-- 2 of 16 --

• Baby, Feminine and Family Care segment organic sales increased three percent versus year ago. Baby
Care organic sales increased mid-single digits driven by a unit volume increase, primarily in Greater
China and North America, and favorable premium product mix, partially offset by lower pricing,
primarily in North America. Feminine Care organic sales increased low single digits driven by
favorable product mix and innovation-based pricing, primarily in North America, partially offset by a
unit volume decline in Europe. Family Care organic sales increased low single digits driven by a unit
volume increase, partially offset by merchandising investments.
Diluted net earnings per share increased by one percent to $1.97. Core earnings per share increased
one percent to $2.00 and Currency-neutral Core EPS was unchanged versus the prior year.
Reported gross margin for the quarter decreased 160 basis points versus the prior year. Core gross
margin and currency-neutral Core gross margin for the quarter decreased 150 basis points versus the prior
year and excluded the impact from incremental restructuring charges. The decrease was driven by 140
basis points of higher costs from commodities, 140 basis points of product reinvestments, 50 basis points
of unfavorable mix and 10 basis points of rounding and other items, partially offset by 120 basis points of
gross productivity savings, 50 basis points of tariff impact from lower costs and recognized recoveries and
20 basis points of increased pricing.
Reported selling, general and administrative expense (SG&A) as a percentage of sales declined 90
basis points versus year ago. Core SG&A as a percentage of sales decreased 80 basis points versus year
ago and decreased 70 basis points on a currency-neutral basis. Core SG&A excluded the impact from
incremental restructuring charges. The decline was driven by 130 basis points of productivity savings and
100 basis points of net sales growth leverage, partially offset by 120 basis points of reinvestments and 40
basis points of rounding and other items.
Reported operating margin for the quarter decreased 70 basis points versus the prior year.
Excluding the impact of non-core restructuring charges, core operating margin decreased 80 basis points
versus the prior year and decreased 90 basis points on a currency-neutral basis. Core operating margin
included gross productivity savings of 250 basis points.
Fiscal Year 2027 Guidance
P&G updated its guidance range for fiscal 2027 all-in sales growth to be in the range of two to four
percent versus the prior year, reflecting the acquisition of Thorne as of October 1, 2026. The Company
maintained its outlook for organic sales growth in the range of one to three percent versus the prior year.

-- 3 of 16 --

Included in the organic sales growth guidance is a headwind of 30 to 50 basis points from brand, product
form and go-to-market discontinuations.
P&G maintained its fiscal 2027 diluted net earnings per share growth to be in the range of one to
five percent versus fiscal 2026 diluted net EPS of $6.62. P&G also maintained its fiscal 2027 core
earnings per share growth to be in the range of in-line to three percent versus fiscal 2026 core EPS of
$6.89. This outlook equates to a range of $6.89 to $7.11 per share, with a mid-point estimate of $7.00, or
an increase of approximately one and a half percent.
P&G now expects a commodity cost headwind of approximately $1.4 billion after tax driven by
higher raw materials, energy and transportation costs, $300 million after-tax from higher net interest
expense, $150 million after-tax from lower non-operating income and $50 million after-tax from
unfavorable foreign exchange rates. Combined, these impacts equate to a headwind of $0.79 per share for
fiscal 2027, or an eleven percent drag on core EPS growth.
The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate
measures without unreasonable efforts given the unpredictability of the timing and amounts of discrete
items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.
P&G now expects a core effective tax rate to be in the range of 20% to 21% in fiscal 2027.
Capital spending is estimated to be in the range of four and a half to five and a half percent of
fiscal 2027 net sales.
P&G continues to expect free cash flow productivity of 85% to 90% and expects to pay over $10
billion in dividends and to repurchase approximately $5 billion of common shares in fiscal 2027.

-- 4 of 16 --

Forward-Looking Statements
Certain statements in this release, other than purely historical information, including estimates,
projections, statements relating to our business plans, objectives and expected operating results, and the
assumptions upon which those statements are based, are "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are
identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy,"
"future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely
result" and similar expressions. Forward-looking statements are based on current expectations and
assumptions, which are subject to risks and uncertainties that may cause results to differ materially from
those expressed or implied in the forward-looking statements. We undertake no obligation to update or
revise publicly any forward-looking statements, whether because of new information, future events or
otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without
limitation: (1) the ability to successfully manage global financial risks, including foreign currency
fluctuations, changes in global interest rates and rate differentials, currency exchange or pricing controls
and tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including
reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to
effect the expected share repurchases and dividend payments; (3) the ability to successfully manage
uncertainties related to changing political and geopolitical conditions and potential implications such as
exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations,
sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our
banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply
arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing
plant arrangements) and to manage disruption of business due to various factors, including ones outside of
our control, such as natural disasters, conflicts or acts of war, terrorism or disease outbreaks; (6) the ability
to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials
and costs of labor, transportation, energy, pensions and healthcare; (7) the ability to compete with our
local and global competitors in new and existing sales channels, including by successfully responding to
competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to
manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity
by successfully managing real or perceived issues, including concerns about safety, quality, ingredients,
efficacy, packaging content, cyber incidents, supply chain practices, social or environmental practices or
similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and
operational risk associated with third-party relationships, such as our suppliers, contract manufacturers,

-- 5 of 16 --

distributors, contractors and external business partners; (11) the ability to rely on and maintain key
company and third-party information and operational technology systems, networks and services and
maintain the security and functionality of such systems, networks and services and the data contained
therein; (12) the ability to successfully manage demand, supply and operational challenges; (13) the ability
to stay on the leading edge of innovation, obtain necessary intellectual property protections and
successfully respond to changing consumer habits, evolving and more fragmented digital marketing and
selling platform requirements and technological advances attained by, and patents granted to, competitors;
(14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in
each case to achieve the Company’s overall business strategy and financial objectives, without impacting
the delivery of base business objectives; (15) the ability to successfully achieve productivity
improvements and cost savings and manage ongoing organizational changes while successfully
identifying, developing and retaining key employees, including in key growth markets where the
availability of skilled or experienced employees may be limited; (16) the ability to successfully manage
current and expanding regulatory and legal requirements and matters (including, without limitation, those
laws, regulations, policies and related interpretations involving product liability, product and packaging
composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy,
cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due
diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters
within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and
(18) the ability to continue delivering progress towards our environmental sustainability ambitions.
For additional information concerning factors that could cause actual results and events to differ
materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

-- 6 of 16 --

About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality,
leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®,
Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®,
Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations
in approximately 65 countries worldwide. Please visit https://www.pg.com for the latest news and
information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
# # #
P&G Media Contacts:
Wendy Kennedy, 513.780.7212
Holly Stutz Smith, 513.659.9949
P&G Investor Relations Contact:
Keri Cowan, 513.983.2414
Category: PG-IR

-- 7 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Earnings Information
Three Months Ended September 30
Amounts in millions except per share amounts 2026 2025 % Chg
NET SALES $ 23,276 $ 22,386 4%
Cost of products sold 11,678 10,887 7%
GROSS PROFIT 11,598 11,499 1%
Selling, general and administrative expense 5,661 5,643 —%
OPERATING INCOME 5,937 5,856 1%
Interest expense (223) (197) 13%
Interest income 102 108 (6)%
Other operating income/(expense), net 207 268 (23)%
EARNINGS BEFORE INCOME TAXES 6,023 6,034 —%
Income taxes 1,267 1,253 1%
NET EARNINGS 4,757 4,781 (1)%
Less: Net earnings attributable to noncontrolling interests 26 31 (16)%
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 4,731 $ 4,750 —%
EFFECTIVE TAX RATE 21.0 % 20.8 %
NET EARNINGS PER COMMON SHARE (1)
Basic $ 2.00 $ 2.00 —%
Diluted $ 1.97 $ 1.95 1%
DIVIDENDS PER COMMON SHARE $ 1.0885 $ 1.0568
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,407.2 2,436.8
COMPARISONS AS A % OF NET SALES Basis Pt Chg
Gross profit 49.8% 51.4% (160)
Selling, general and administrative expense 24.3% 25.2% (90)
Operating income 25.5% 26.2% (70)
Earnings before income taxes 25.9% 27.0% (110)
Net earnings 20.4% 21.4% (100)
Net earnings attributable to Procter & Gamble 20.3% 21.2% (90)
(1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter &
Gamble.
Certain columns and rows may not add due to rounding.

-- 8 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Earnings Information
Three Months Ended September 30, 2026
Amounts in millions Net Sales
% Change
Versus Year
Ago Earnings/(Loss) Before
Income Taxes
% Change
Versus Year
Ago Net Earnings/(Loss)
% Change
Versus Year
Ago
Beauty $ 4,410 6% $ 1,139 1% $ 868 (1)%
Grooming 1,889 4% 619 6% 477 3%
Health Care 3,318 3% 1,029 10% 783 9%
Fabric & Home Care 8,205 4% 2,080 4% 1,601 3%
Baby, Feminine & Family Care 5,322 3% 1,390 (4)% 1,060 (4)%
Corporate 132 N/A (234) N/A (32) N/A
Total Company $ 23,276 4% $ 6,023 —% $ 4,757 (1)%
Three Months Ended September 30, 2026
Net Sales Drivers (1) Volume Organic
Volume Foreign
Exchange Price Mix A&D (2) Net Sales
Beauty 2.2% 2.2% 1.1% 0.7% 2.5% —% 6.4%
Grooming (0.4)% (0.4)% (0.4)% 3.5% 1.5% (0.1)% 4.0%
Health Care (2.9)% (2.9)% 0.4% 2.8% 2.8% (0.1)% 3.1%
Fabric & Home Care 4.3% 4.3% (0.6)% (0.3)% 0.8% —% 4.2%
Baby, Feminine & Family Care 2.3% 2.3% (0.1)% (1.2)% 1.8% —% 2.9%
Total Company 2.4% 2.4% —% 0.4% 1.1% —% 4.0%
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2) Acquisitions and Divestitures excluding volume impact.
Certain columns and rows may not add due to rounding.

-- 9 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Three Months Ended September 30
Amounts in millions 2026 2025
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD $ 9,942 $ 9,556
OPERATING ACTIVITIES
Net earnings 4,757 4,781
Depreciation and amortization 810 761
Share-based compensation expense 98 121
Deferred income taxes 115 53
(Gain)/loss on sale of assets (20) (3)
Change in accounts receivable (589) (305)
Change in inventories (349) (303)
Change in accounts payable 1,149 648
Other (204) (344)
TOTAL OPERATING ACTIVITIES 5,767 5,408
INVESTING ACTIVITIES
Capital expenditures (1,366) (1,200)
Proceeds from asset sales 27 8
Acquisitions, net of cash acquired — (5)
Other investing activity (121) (338)
TOTAL INVESTING ACTIVITIES (1,460) (1,535)
FINANCING ACTIVITIES
Dividends to shareholders (2,603) (2,549)
Additions to short-term debt with original maturities of more than three months — 1,123
Reductions in short-term debt with original maturities of more than three months (157) (1,800)
Net additions/(reductions) to other short-term debt 5,758 2,108
Reductions in long-term debt (747) (3)
Treasury stock purchases (1,250) (1,250)
Impact of stock options and other 143 134
TOTAL FINANCING ACTIVITIES 1,144 (2,239)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND
RESTRICTED CASH (29) (20)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 5,423 1,615
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 15,365 $ 11,171
Certain columns and rows may not add due to rounding.

-- 10 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
Amounts in millions September 30, 2026 June 30, 2026
Cash and cash equivalents $ 15,365 $ 9,942
Accounts receivable 6,620 6,056
Inventories 8,485 8,170
Prepaid expenses and other current assets 2,038 2,040
TOTAL CURRENT ASSETS 32,508 26,208
Property, plant and equipment, net 25,519 25,360
Goodwill 41,197 41,276
Trademarks and other intangible assets, net 21,359 21,444
Other noncurrent assets 12,549 12,231
TOTAL ASSETS $ 133,132 $ 126,521
Accounts payable $ 17,056 $ 16,306
Accrued and other liabilities 10,911 11,091
Debt due within one year 17,028 11,296
TOTAL CURRENT LIABILITIES 44,996 38,694
Long-term debt 21,897 22,842
Deferred income taxes 5,949 5,760
Other noncurrent liabilities 4,954 4,914
TOTAL LIABILITIES 77,795 72,210
TOTAL SHAREHOLDERS' EQUITY 55,337 54,311
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 133,132 $ 126,521
Certain columns and rows may not add due to rounding.

-- 11 of 16 --

The Procter & Gamble Company
Exhibit 1: Non-GAAP Measures
The following provides definitions of the non-GAAP measures used in Procter & Gamble's
October 22, 2026 earnings release and the reconciliation to the most closely related GAAP measures. We
believe that these measures provide useful perspective on underlying business trends (i.e., trends
excluding non-recurring or unusual items) and results and provide a supplemental measure of period-to-
period results. The non-GAAP measures described below are used by management in making operating
decisions, allocating financial resources and for business strategy purposes. These measures may be useful
to investors, as they provide supplemental information about business performance and provide investors a
view of our business results through the eyes of management. Certain of these measures are also used to
evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP
measures are not intended to be considered by the user in place of the related GAAP measures but rather
as supplemental information to our business results. These non-GAAP measures may not be the same as
similar measures used by other companies due to possible differences in method and in the items or events
being adjusted. The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax
rate measures because the Company cannot predict the timing and amounts of discrete items such as
acquisition and divestitures, which could significantly impact GAAP results. Note that certain columns
and rows may not add due to rounding.
The Core earnings measures included in the following reconciliation tables refer to the equivalent
GAAP measures adjusted as applicable for the following item:
• Incremental restructuring: The Company has historically had an ongoing level of restructuring
activities of approximately $250 - $500 million before tax annually. In June 2025, the Company
announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost
structure and competitiveness. The Company expects to incur approximately $2 billion in before-tax
restructuring costs over two years and has incurred over half of the costs under this plan in fiscal 2026,
with the remainder expected to be incurred in fiscal 2027. The adjustments to Core earnings include the
restructuring charges that exceed the normal, recurring level of restructuring charges.
We do not view the above item to be part of our sustainable results, and their exclusion from Core
earnings measures provides a more comparable measure of year-on-year results. These items are also
excluded when evaluating senior management in determining their at-risk compensation.
Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the
impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We
believe this measure provides investors with a supplemental understanding of underlying sales trends by

-- 12 of 16 --

providing sales growth on a consistent basis. This measure is used in assessing the achievement of
management goals for at-risk compensation.
Core EPS and Currency-neutral Core EPS: Core earnings per share, or Core EPS, is a measure of
diluted net earnings per common share (diluted EPS) adjusted for items as indicated. Currency-neutral
Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of
foreign exchange. Management views these non-GAAP measures as useful supplemental measures of
Company performance over time.
Core gross margin and Currency-neutral Core gross margin: Core gross margin is a measure of the
Company's gross margin adjusted for items as indicated. Currency-neutral Core gross margin is a measure
of the Company's Core gross margin excluding the incremental current year impact of foreign exchange.
Management believes these non-GAAP measures provide a supplemental perspective to the Company’s
operating efficiency over time.
Core selling, general and administrative (SG&A) expense as a percentage of sales and Currency-
neutral Core SG&A expense as a percentage of sales: Core SG&A expense as a percentage of sales is a
measure of the Company's selling, general and administrative expense as a percentage of net sales adjusted
for items as indicated. Currency-neutral Core SG&A expense as a percentage of sales is a measure of the
Company's Core selling, general and administrative expense as a percentage of net sales excluding the
incremental current year impact of foreign exchange. Management believes these non-GAAP measures
provide a supplemental perspective to the Company's operating efficiency over time.
Core operating margin and Currency-neutral Core operating margin: Core operating margin is a
measure of the Company's operating margin adjusted for items as indicated. Currency-neutral Core
operating margin is a measure of the Company's Core operating margin excluding the incremental current
year impact of foreign exchange. Management believes these non-GAAP measures provide a
supplemental perspective to the Company’s operating efficiency over time.
Free cash flow: Free cash flow is defined as operating cash flow less capital spending. Free cash
flow represents the cash that the Company is able to generate after taking into account planned
maintenance and asset expansion. We view free cash flow as an important measure because it is one factor
used in determining the amount of cash available for dividends, share repurchases, acquisitions and other
discretionary investments.
Free cash flow productivity: Free cash flow productivity is defined as the ratio of free cash flow to
net earnings. We view free cash flow productivity as a useful measure to help investors understand P&G’s
ability to generate cash. Free cash flow productivity is used by management in making operating
decisions, in allocating financial resources and for budget planning purposes. This measure is also used in
assessing the achievement of management goals for at-risk compensation.
Certain columns and rows may not add due to rounding.

-- 13 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended September 30, 2026
Amounts in millions except per share amounts As Reported
(GAAP) Incremental
Restructuring Core
(Non-GAAP)
Cost of products sold $ 11,678 $ (44) $ 11,634
Gross profit 11,598 44 11,642
Gross margin 49.8 % 0.2 % 50.0 %
Currency impact to Core gross margin — %
Currency-neutral Core gross margin 50.0 %
Selling, general and administrative expense 5,661 (54) 5,607
Selling, general and administrative expense as a % of net sales 24.3 % (0.2) % 24.1 %
Currency impact to Core selling, general and administrative expense as a % of net sales 0.1 %
Currency-neutral Core selling, general and administrative expense as a % of net sales 24.2 %
Operating income 5,937 98 6,035
Operating margin 25.5 % 0.4 % 25.9 %
Currency impact to Core operating margin (0.1) %
Currency-neutral Core operating margin 25.8 %
Other non-operating income/(expense), net 207 2 209
Income taxes 1,267 20 1,287
Net earnings 4,757 80 4,837
Less: Net earnings attributable to noncontrolling interests 26 2 28
Net earnings attributable to P&G 4,731 77 4,808
Core EPS
Diluted net earnings per common share (1) $ 1.97 $ 0.03 $ 2.00
Currency impact to Core EPS $ (0.01)
Currency-neutral Core EPS $ 1.99
Diluted weighted average common shares outstanding 2,407.2
(1) Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

-- 14 of 16 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended September 30, 2025
Amounts in millions except per share amounts As Reported
(GAAP) Incremental
Restructuring Core
(Non-GAAP)
Cost of products sold $ 10,887 $ (39) $ 10,848
Gross profit 11,499 39 11,537
Gross margin 51.4 % 0.1 % 51.5 %
Currency impact to Core gross margin 0.2 %
Currency-neutral Core gross margin 51.7 %
Selling, general and administrative expense 5,643 (77) 5,566
Selling, general and administrative expense as a % of net sales 25.2 % (0.3) % 24.9 %
Currency impact to Core selling, general and administrative expense as a % of net sales 0.3 %
Currency-neutral Core selling, general and administrative expense as a % of net sales 24.6 %
Operating income 5,856 116 5,972
Operating margin 26.2 % 0.5 % 26.7 %
Currency impact to Core operating margin 0.4 %
Currency-neutral Core operating margin 27.1 %
Other non-operating income/(expense), net 268 7 275
Income taxes 1,253 23 1,276
Net earnings attributable to P&G 4,750 100 4,850
Core EPS
Diluted net earnings per common share (1) $ 1.95 $ 0.04 $ 1.99
Currency impact to earnings $ —
Currency-neutral EPS $ 1.99
Diluted weighted average common shares outstanding 2,436.8
(1) Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Gross margin (160) BPS
Core gross margin (150) BPS
Currency-neutral Core gross margin (150) BPS
Selling, general and administrative expense as a % of net sales (90) BPS
Core selling, general and administrative expense as a % of net sales (80) BPS
Currency-neutral Core selling, general and administrative as a % of net sales (70) BPS
Operating margin (70) BPS
Core operating margin (80) BPS
Currency-neutral Core operating margin (90) BPS
Diluted EPS 1 %
Core EPS 1 %
Currency-neutral Core EPS — %
Certain columns and rows may not add due to rounding.

-- 15 of 16 --

Organic sales growth:
July - September 2026 Net Sales Growth Foreign Exchange
Impact Acquisition &
Divestiture Impact Organic Sales
Growth
Beauty 6.4% (1.1)% —% 5.4%
Grooming 4.0% 0.4% 0.2% 4.5%
Health Care 3.1% (0.4)% —% 2.7%
Fabric & Home Care 4.2% 0.6% —% 4.8%
Baby, Feminine & Family Care 2.9% 0.1% —% 3.0%
Total Company 4.0% —% —% 4.0%
Total Company Net Sales Growth Combined Foreign Exchange &
Acquisition/Divestiture Impact/Other (1) Organic Sales Growth
FY 2027 (Estimate) +2% to +4% -1% +1% to +3%
(1) Combined Foreign Exchange & Acquisition/Divestiture Impact/Other includes foreign exchange impacts, the volume and mix impact of acquisitions and
divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Core EPS growth:
Total Company Diluted EPS Growth Impact of Incremental Non-Core Items (1) Core EPS Growth
FY 2027 (Estimate) +1% to +5% -1% to -2% -% to +3%
(1) Includes the impact of incremental non-core restructuring charges including the portfolio and productivity plan.
Free cash flow (dollar amounts in millions):
Three Months Ended September 30, 2026
Operating Cash Flow Capital Spending Free Cash Flow
$5,767 $(1,366) $4,401
Free cash flow productivity (dollar amounts in millions):
Three Months Ended September 30, 2026
Free Cash Flow Net Earnings Free Cash Flow Productivity
$4,401 $4,757 93%
Certain columns and rows may not add due to rounding.

-- 16 of 16 --